Cannabis
Flora Appoints Author of Colombian Medical Cannabis Law to Advisory Board; Aaron Atin as Corporate Secretary
TORONTO, Jan. 18, 2021 (GLOBE NEWSWIRE) — Flora Growth Corp. (“Flora” or the “Company”) is pleased to announce the appointment of Juan Manuel Galán Pachon, a former Colombian senator and the author of the Colombian medical cannabis law, to its board of strategic advisors. Flora has also appointed Aaron Atin as its new corporate secretary.
“As a Colombia-based cannabis company, we are thrilled to have someone of Mr. Galán’s pedigree join our advisory board,” commented Flora’s President & CEO, Luis Merchan. Mr. Merchan continued, “As the author of the law that legalized medical cannabis in Colombia and a true advocate for drug policy reform, we expect he will be an invaluable advisor to help Flora grow its cannabis operations in Colombia and throughout international markets.”
About Juan Manuel Galán Pachon
Mr. Galán currently serves as a senior consultant to The World Bank. He is a Colombian politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is the son and political heir of the late political activist, politician, and presidential candidate, Luis Carlos Galán Sarmiento. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience.
During his time as a senator, Mr. Galán was an extremely active politician and promoter of drug policy reform; he proposed overcoming consumption prohibition and criminalization in order to implement a policy focused on public health and human rights. He has been a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.
Mr. Galán commented on his new role, “I am excited to support Flora’s emergence in the cannabis industry both within Colombia and internationally. They are a cannabis company headquartered in Canada but rooted in Colombia, with a strong team that will do an excellent job of representing our country’s cannabis industry on the global stage.”
About Aaron Atin
Mr. Aaron Atin is a corporate lawyer who works as a legal consultant to various public companies in the mining and technology industries. He was previously an associate at a large Toronto corporate law firm, where he worked on a variety of corporate, securities and commercial transactions. Mr. Atin studied at the University of Toronto, Faculty of Law, and the University of Waterloo, where he obtained a Juris Doctor and a Bachelor of Arts degree, respectively.
Flora Growth Corp.
Flora is a vertically integrated cannabis company striving to be a globally recognized cannabis brand by leveraging low-cost production of cannabis to supply CBD oil to our portfolio of consumer and medical brands. Flora prioritizes organic ingredients and value-chain sustainability across its portfolio to create products that help consumers restore and thrive.
For further information, contact:
Evan Veryard
+1 416 571 9037
[email protected]
Website: www.floragrowth.ca
Cautionary Notes
This news release may contain forward-looking statements. These statements include statements regarding the appointment of an advisor and the Company’s operations, strategy, and future plans and objectives, including its growth in Colombia and internationally. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially. We do not assume any obligation to update any forward-looking statements, except as required by applicable laws.
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE2 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis1 day ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt23 hours ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace